摩根士丹利近日调整了对诺和诺德(Novo Nordisk)的投资评级,将其从原先的“减持”提升至“持股观望”。与此同时,该投行将诺和诺德的目标股价从42美元下调至40美元。此次评级调整反映了摩根士丹利对诺和诺德未来表现的重新评估。
摩根士丹利近日调整了对诺和诺德(Novo Nordisk)的投资评级,将其从原先的“减持”提升至“持股观望”。与此同时,该投行将诺和诺德的目标股价从42美元下调至40美元。此次评级调整反映了摩根士丹利对诺和诺德未来表现的重新评估。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.